
J. Nadine Gracia

Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials

MILKEN INSTITUTE ANNOUNCES THE RETURN OF JAPAN SYMPOSIUM IN TOKYO, RUNNING FROM MARCH 22-23, AT THE RITZ-CARLTON

Milken Institute Announces Tech Hub Partners Program to Link Business Leaders and Investors to Regional Tech Innovation Opportunities

An Update from MI Health—July 2024
